News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
October, 2024
October 2024
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Most viewed in the last 7 days from JAMA Oncology
Photo taken from JAMA Oncology/LinkedIn
Apr 3, 2024, 06:05

Most viewed in the last 7 days from JAMA Oncology

JAMA Oncology shared a post on LinkedIn:

“Most viewed in the last 7 days from JAMA Oncology: Do patients with resectable NSCLC and tumor programmed cell death 1 ligand 1 levels less than 1% benefit from neoadjuvant chemo immunotherapy?”

Additional information.
Source: JAMA Oncology/LinkedIn

cancer cell death chemo-immunotherapy JAMA Oncology NSCLC OncoDaily Oncology patients
Special Coverage
Dialogues
Oct 4, 2024, 21:03
United Against Cancer v1: Luke Thomas and Zainab Shinkafi-Bagudu on Advancing Childhood Cancer Care
Blog
Oct 4, 2024, 19:26
A day of mission-driven impact toward a world without cancer - AIM-HI Accelerator Fund
Blog
Oct 4, 2024, 19:20
The Lancet Oncology Commission presented at ASTRO24 - ESTRO
Blog
Oct 4, 2024, 19:14
Louise Turner - The healer and teacher
Blog
Oct 4, 2024, 17:55
Enhancing Quality of Life and Health Beyond Cancer - Sylvester Comprehensive Cancer Center
Career
Oct 4, 2024, 17:47
Hana Chaar Choueib Is Running For The UICC Board of Directors
Blog
Oct 4, 2024, 17:28
Raffaele Colombo: sBLA for T-DXd has been accepted by FDA HER2-low or HER2-ultralow breast cancer
Blog
Oct 4, 2024, 17:19
Bishal Gyawali: Our CSO Symposium in Vall d’Hebron Hospital
Blog
Oct 4, 2024, 17:11
Registration opens for the 7th Translational Research Conference on Multiple Myeloma - ESH
Career
Oct 4, 2024, 17:02
Colton Ladbury receives the ARRO Resident Educator of the Year Award
Blog
Oct 4, 2024, 16:55
Exclusive insights into the latest breakthroughs at the NFCR Global Summit and Award Ceremonies For Cancer Research and Entrepreneurship - AFCR
Blog
Oct 4, 2024, 16:52
Zainab Shinkafi-Bagudu: We all deserve an equal chance to beat cancer